Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.

Masaya KoshizakaKo IshikawaRyoichi IshibashiSho TakahashiKenichi SakamotoHidetaka YokohYusuke BabaShintaro IdeKana IdeTakahiro IshikawaShunichiro OnishiKazuki KobayashiMinoru TakemotoTakuro HorikoshiRyota ShimofusaYoshiro MaezawaKoutaro Yokote

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

The study was registered at https://www.umin.ac.jp/ctr/ (UMIN-ID: UMIN 000015170).

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
insulin resistance
adipose tissue
prognostic factors
cardiovascular disease
metabolic syndrome
middle aged
patient reported